N-Acetylneuraminylgalactosylglucosylceramide beta-1,4-N-acetylgalactosaminyltransferase (2.4.1.165)

Follow

Industry

CPC
C12Y204/01165

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12YENZYMES C12Y204/00Glycosyltransferases (2.4)

Current Industry

C12Y204/01165N-Acetylneuraminylgalactosylglucosylceramide beta-1,4-N-acetylgalactosaminyltransferase (2.4.1.165)

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods and materials for GALGT2 gene therapy
- Patent number 12,121,595
- Issue date Oct 22, 2024
- Research Institute at Nationwide Children's Hospital
- Paul Taylor Martin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and materials for GALGT2 gene therapy
- Patent number 10,980,897
- Issue date Apr 20, 2021
- Research Institute at Nationwide Children's Hospital
- Paul Taylor Martin
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
METHODS AND MATERIALS FOR GALGT2 GENE THERAPY
- Publication number 20250025578
- Publication date Jan 23, 2025
- Research Institute at Nationwide Children's Hospital
- Paul Taylor Martin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods and Materials for GALGT2 Gene Therapy
- Publication number 20210220484
- Publication date Jul 22, 2021
- RESEARCH INSTITUTE AT NATIONWIDE CHILDEREN'S HOSPITAL
- Paul Taylor Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND MATERIALS FOR GALGT2 GENE THERAPY
- Publication number 20180250423
- Publication date Sep 6, 2018
- Research Institute at Nationwide Children's Hospital
- Paul Taylor Martin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE